Abattis CEO Attending the Canada Cannabis Conference
June 22, 2015 (Source: Abattis Bioceuticals Corp.) — Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (OTCQX: ATTBF) (CSE: ATT), a botanical drug development company that develops and licenses natural health products, medicines, extractions and ingredients for the pharmaceutical, nutraceutical, bioceutical and cosmetic markets, some of which will contain cannabinoid compounds, would like to announce it will be attending the Canada Cannabis Conference, presented by Jacob Securities Inc. (“Jacob”) on June 22, 2015 in Toronto, Ontario.
June 22, 2015
7:30 am ET- 4:30 pm ET
Grand Ballroom, Trump Hotel, 325 Bay St, Toronto, ON M5H 4G3
Bill Fleming, CEO of Abattis will participate in the Canada Cannabis Conference, presented by Jacob Bill Fleming commented, “Abattis has made investments in technologies that support this industry. We consistently look for opportunities to participate in varied markets all connected by a common global purpose and customer base: seeking health through natural products. I am excited at the opportunity to discuss the prospects Abattis sees in the immediate future; I look forward to the chance to speak with investors in the industry and collaborate with leading industry voices.”
The Canada Cannabis Conference is the first investor conference of its kind in Canada. The conference will feature presentations, panel discussions and one on one break out discussions with leading industry experts and executives. Attendees will be attending presentations on the current state of the industry and receive keys insights to its ongoing development.
ON BEHALF OF THE BOARD
Bill Fleming, CEO
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
FORWARD LOOKING INFORMATION
This press release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks various risk factors discussed in the Company’s Management’s Discussion and Analysis under the Company’s profile on www.sedar.com. While the Company may elect to, it does not undertake to update this information at any particular time.
Raj Shah has been a member of the InvestorIntel.com team for the last nearly 9 years. Recruited from Merrill Lynch, he has over 13 years’ ... <Read more about Raj Shah>